BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15371687)

  • 1. Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection.
    White NB; Greenstein SM; Cantafio AW; Schechner R; Glicklich D; McDonough P; Pullman J; Mohandas K; Boctor F; Uehlinger J; Tellis V
    Transplantation; 2004 Sep; 78(5):772-4. PubMed ID: 15371687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
    Ibernón M; Gil-Vernet S; Carrera M; Serón D; Moreso F; Bestard O; Cruzado JM; Grinyó JM
    Transplant Proc; 2005 Nov; 37(9):3743-5. PubMed ID: 16386524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation.
    Lehrich RW; Rocha PN; Reinsmoen N; Greenberg A; Butterly DW; Howell DN; Smith SR
    Hum Immunol; 2005 Apr; 66(4):350-8. PubMed ID: 15866697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.
    Montgomery RA; Zachary AA; Racusen LC; Leffell MS; King KE; Burdick J; Maley WR; Ratner LE
    Transplantation; 2000 Sep; 70(6):887-95. PubMed ID: 11014642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection.
    Rocha PN; Butterly DW; Greenberg A; Reddan DN; Tuttle-Newhall J; Collins BH; Kuo PC; Reinsmoen N; Fields T; Howell DN; Smith SR
    Transplantation; 2003 May; 75(9):1490-5. PubMed ID: 12792502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and late humoral rejection: a clinicopathologic entity in two times.
    Péfaur J; Díaz P; Panace R; Salinas P; Fiabane A; Quinteros N; Chea R; Naranjo E; Wurgaft A; Beltran E; Elgueta S; Wegmann ME; Gajardo JG; Contreras L
    Transplant Proc; 2008 Nov; 40(9):3229-36. PubMed ID: 19010241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
    Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
    Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
    Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization and renal transplant: plasmapheresis/IVIG standard dose in patients with high immunological risk.
    Flores-Gama F; Mondragón-Ramírez GA; Bochicchio-Riccardelli T
    Cir Cir; 2009; 77(5):369-74. PubMed ID: 19944025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.
    Stegall MD; Gloor J; Winters JL; Moore SB; Degoey S
    Am J Transplant; 2006 Feb; 6(2):346-51. PubMed ID: 16426319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New treatments for acute humoral rejection of kidney allografts.
    Venetz JP; Pascual M
    Expert Opin Investig Drugs; 2007 May; 16(5):625-33. PubMed ID: 17461736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a negative conversion trial and subsequent living donor kidney transplant outcome in recipients with a positive lymphocyte crossmatch.
    Huh KH; Kim SI; Joo DJ; Ju MK; Chang HK; Kim HJ; Kim YS; Kim MS
    Nephron Clin Pract; 2009; 111(1):c49-54. PubMed ID: 19052470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
    Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of simultaneous acute antibody-mediated rejection and acute cellular rejection with alemtuzumab in kidney transplantation: a case report.
    Jirasiritham S; Khunprakant R; Techawathanawanna N; Jirasiritham S; Mavichak V
    Transplant Proc; 2010 Apr; 42(3):987-9. PubMed ID: 20430222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive plasmapheresis and intravenous immunoglobulin for treatment of antibody-mediated rejection after kidney transplant.
    Ruangkanchanasetr P; Satirapoj B; Termmathurapoj S; Namkhanisorn K; Suaywan K; Nimkietkajorn V; Luesutthiviboon L
    Exp Clin Transplant; 2014 Aug; 12(4):328-33. PubMed ID: 25095710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmapheresis and intravenous immunoglobulin in early antibody-mediated rejection of the renal allograft: a single-center experience.
    Slatinska J; Honsova E; Burgelova M; Slavcev A; Viklicky O
    Ther Apher Dial; 2009 Apr; 13(2):108-12. PubMed ID: 19379149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute antibody-mediated rejection in paediatric renal transplant recipients.
    Kranz B; Kelsch R; Kuwertz-Bröking E; Bröcker V; Wolters HH; Konrad M
    Pediatr Nephrol; 2011 Jul; 26(7):1149-56. PubMed ID: 21461632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.
    Gupta G; Abu Jawdeh BG; Racusen LC; Bhasin B; Arend LJ; Trollinger B; Kraus E; Rabb H; Zachary AA; Montgomery RA; Alachkar N
    Transplantation; 2014 Jun; 97(12):1240-6. PubMed ID: 24937198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful kidney transplantation in highly sensitized patients.
    Zhang W; Chen D; Chen Z; Zeng F; Ming C; Lin Z; Zhou P; Chen G; Chen X
    Front Med; 2011 Mar; 5(1):80-5. PubMed ID: 21681679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.